Clostridium difficile infection (CDI) is a common cause of diarrhea in hospitalized patients. Around the world, the incidence and severity of CDI appears to be increasing, particularly in the northern hemisphere. Mitchell and Gardner (2012) conducted an integrative review to investigate and describe mortality in hospitalized patients with CDI.
Â
A search of the literature between Jan. 1, 2005 and April 30, 2011 focusing on mortality and CDI in hospitalized patients was conducted using electronic databases. Papers were reviewed and analyzed individually and themes were combined using integrative methods.
The researchers report that all-cause mortality at 30 days varied from 9 percent to 38 percent. Three studies report attributable mortality at 30 days, varying from 5.7 percent to 6.9 percent. In hospital mortality ranged from 8 percent to 37.2 percent
Â
Mitchell and Gardner (2012) concluded that all-cause 30-day mortality appeared to be high, with 15 studies indicating a mortality of 15 percent or greater. Findings support the notion that CDI is a serious infection and measures to prevent and control CDI are needed. Future studies investigating the mortality of CDI in settings outside of Europe and North America are needed. Similarly, future studies should include data on patient co-morbidities. Their research was published in Antimicrobial Resistance and Infection Control.
Reference: Mitchell BG and Gardner A. Mortality and Clostridium difficile infection: a review. Antimicrobial Resistance and Infection Control 2012, 1:20 doi:10.1186/2047-2994-1-20
Â
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.
2 Commerce Drive
Cranbury, NJ 08512